相关实验视频

Updated: Jul 28, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

一种具有瘤细胞特异性的西斯丁合物在癌模型中表现出抗瘤作用

Stefan Mrdenovic^1,2,3, Yanping Wang⁴, Lijuan Yin²

¹Division of Hematology, Department of Internal Medicine, University Hospital Osijek, Osijek, Croatia.

|June 2, 2023

概括

用DZ-CIS进行细胞下向癌症治疗显示出治疗清细胞细胞癌 (ccRCC) 的前景. 这种新的方法可以规避耐药性,降低毒性,为癌提供潜在的更安全,更有效的治疗选择.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

清细胞细胞癌 (ccRCC) 对传统化疗和向疗法表现出显著的耐药性.
以亚细胞为目标的癌症治疗为克服这种抵抗提供了一个潜在的策略.

研究的目的:

评估DZ-CIS的疗效和安全性,这是一种新的亚细胞向疗法,用于治疗ccRCC.
调查DZ-CIS是否可以绕过ccRCC中现有的阻力机制.

主要方法:

DZ-CIS是一种合的甲碳酸染料 (HMCD) 和西斯 (CIS),对人类ccRCC细胞系 (Caki-1,786-O,ACHN,SN12C) 和小鼠Renca细胞进行了测试.
在体内研究涉及实验性小鼠模型,以评估瘤形成抑制和毒性.
机理学研究检查了DZ-CIS积累,线粒体损伤和诱导亡.

主要成果:

在体内,DZ-CIS证明了对ccRCC细胞系的剂量依赖性细胞灭菌作用,并抑制了瘤形成.
与单独的西斯丁不同,DZ-CIS在携带瘤的小鼠中没有诱导脏毒性.
通过破坏线粒体和使细胞对mTOR抑制剂敏感,DZ-CIS诱导了ccRCC细胞的亡.

结论:

DZ-CIS对ccRCC具有强大的抗癌活性.
DZ-CIS代表了针对ccRCC的安全有效的亚细胞向治疗策略.
需要进一步对DZ-CIS进行ccRCC治疗的临床研究.

关键词:

细胞死亡细胞死亡西斯普拉丁 (Cisplatin) 是一种结合结合结合结合结合结合结合甲胺碳酸染料的染料是什么脏癌症是什么? 脏癌症是什么

更多相关视频

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...